Evidence map›Paper›PMID 31396261›Full record

ArticleFrontiers in genetics2019

Mengxia Li, Ming Wu, Yu Qin, Jinyi Zhou, Jian Su, Enchun Pan, Qin Zhang, Ning Zhang, Hongyan Sheng, Jiayi Dong and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Frontiers in neuroscience · 2021
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Mengxia LiDepartment of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, China.
Ming WuDepartment of Non-communicable Chronic Disease Control, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Yu QinDepartment of Non-communicable Chronic Disease Control, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Jinyi ZhouDepartment of Non-communicable Chronic Disease Control, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Jian SuDepartment of Chronic Disease Prevention and Control, Huai'an City Center for Disease Control and Prevention, Huai'an, China.
Enchun PanDepartment of Chronic Disease Prevention and Control, Huai'an City Center for Disease Control and Prevention, Huai'an, China.
Qin ZhangDepartment of Chronic Disease Prevention and Control, Huai'an City Center for Disease Control and Prevention, Huai'an, China.
Ning ZhangChangshu County Center for Disease Control and Prevention, Suzhou, China.
Hongyan ShengChangshu County Center for Disease Control and Prevention, Suzhou, China.
Jiayi DongDepartment of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, China.
Ye TongDepartment of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, China.
Chong ShenDepartment of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, China.
Nanjing Medical University · CNJiangsu Provincial Center for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Beta-actin (ACTB) loss-of-function mutations result in a pleiotropic developmental disorder of kidney. The present study aims to explore whether the common variants at the

Indexed as

ACTB genediabetic kidney diseaseestimated glomerular filtration ratesingle nucleotide polymorphismstype 2 diabetes mellitus

Identifiers

PMID31396261
PMCPMC6664243
OpenAlexW2964285371

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.